Modern techniques for the diagnostic evaluation of the trephine bone marrow biopsy: Methodological aspects and applications

Progress in Histochemistry and Cytochemistry

Volumn 42, Issue 4, 2008, Pages 203-252

  Fend, Falko ^a   Tzankov, Alexandar ^b   Bink, Karin ^c   Seidl, Stefan ^a   Quintanilla Martinez, Leticia ^c   Kremer, Marcus ^a   Dirnhofer, Stephan ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF BASEL   (Switzerland)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; RNA;

ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; BONE MARROW BIOPSY; CYTOLOGY; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLICULAR LYMPHOMA; HAIRY CELL LEUKEMIA; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPHATIC LEUKEMIA; LYMPHOBLASTOMA; MANTLE CELL LYMPHOMA; METASTASIS; METHODOLOGY; NONHODGKIN LYMPHOMA; NONHUMAN; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; TISSUE MICROARRAY;

BONE MARROW; BONE MARROW DISEASES; BONE MARROW EXAMINATION; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; TISSUE FIXATION;

EID: 38649091350     PISSN: 00796336     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.proghi.2007.10.002     Document Type: Article

References (221)

1. Akcan Y., Tuncer S., Hayran M., Sungur A., and Unal S. PCR on disseminated tuberculosis in bone marrow and liver biopsy specimens: correlation to histopathological and clinical diagnosis. Scand J Infect Dis 29 (1997) 271-274
2. Alers J.C., Krijtenburg P.J., Vissers K.J., and van Dekken H. Effect of bone decalcification procedures on DNA in situ hybridization and comparative genomic hybridization. EDTA is highly preferable to a routinely used acid decalcifier. J Histochem Cytochem 47 (1999) 703-710
3. Andriko J.W., Swerdlow S.H., Aguilera N.I., and Abbondanzo S.L. Is lymphoplasmacytic lymphoma/immunocytoma a distinct entity? A clinicopathologic study of 20 cases. Am J Surg Pathol 25 (2001) 742-751
4. Anon. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood 89 (1997) 3909-3918
5. Antonov J., Goldstein D.R., Oberli A., Baltzer A., Pirotta M., Fleischmann A., et al. Reliable gene expression measurements from degraded RNA by quantitative real-time PCR depend on short amplicons and a proper normalization. Lab Invest 13 (2005) 13
6. Arber D.A. Molecular diagnostic approach to non-Hodgkin's lymphoma. J Mol Diagn 2 (2000) 178-190
7. Arber D.A., Jenkins K.A., and Slovak M.L. CD79 alpha expression in acute myeloid leukemia. High frequency of expression in acute promyelocytic leukemia. Am J Pathol 149 (1996) 1105-1110
8. Attygalle A.D., Diss T.C., Munson P., Isaacson P.G., Du M.Q., and Dogan A. CD10 expression in extranodal dissemination of angioimmunoblastic T-cell lymphoma. Am J Surg Pathol 28 (2004) 54-61
9. Audouin J., Le Tourneau A., Molina T., Camilleri-Broet S., Adida C., Comperat E., et al. Patterns of bone marrow involvement in 58 patients presenting primary splenic marginal zone lymphoma with or without circulating villous lymphocytes. Br J Haematol 122 (2003) 404-412
10. Aurer I., Juhbashi T., Sekine I., Tomonaga M., and Gale R.P. Analysis of BCR/ABL abnormalities in mRNA from 20-year-old paraffin-embedded tissue for BCR/ABL rearrangement by polymerase chain reaction. Acta Haematol 90 (1993) 5-7
11. Baccarani M., Saglio G., Goldman J., Hochhaus A., Simonsson B., Appelbaum F., et al. Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood 108 (2006) 1809-1820
12. Bain B.J. Bone marrow trephine biopsy. J Clin Pathol 54 (2001) 737-742
13. Bavikatty N.R., Ross C.W., Finn W.G., Schnitzer B., and Singleton T.P. Anti-CD10 immunoperoxidase staining of paraffin-embedded acute leukemias: comparison with flow cytometric immunophenotyping. Hum Pathol 31 (2000) 1051-1054
14. Baxter E.J., Scott L.M., Campbell P.J., East C., Fourouclas N., Swanton S., et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 365 (2005) 1054-1061
15. Beck R.C., Tubbs R.R., Hussein M., Pettay J., and Hsi E.D. Automated colorimetric in situ hybridization (CISH) detection of immunoglobulin (Ig) light chain mRNA expression in plasma cell (PC) dyscrasias and non-Hodgkin lymphoma. Diagn Mol Pathol 12 (2003) 14-20
16. Berger F., Felman P., Thieblemont C., Pradier T., Baseggio L., Bryon P.A., et al. Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients. Blood 95 (2000) 1950-1956
17. Bock O., Lehmann U., and Kreipe H. Quantitative intra-individual monitoring of BCR-ABL transcript levels in archival bone marrow trephines of patients with chronic myeloid leukemia. J Mol Diagn 5 (2003) 54-60
18. Bock O., Reising D., and Kreipe H. Multiplex RT-PCR for the detection of common BCR-ABL fusion transcripts in paraffin-embedded tissues from patients with chronic myeloid leukemia and acute lymphoblastic leukemia. Diagn Mol Pathol 12 (2003) 119-123
19. Bock O., Busche G., Koop C., Schroter S., Buhr T., and Kreipe H. Detection of the single hotspot mutation in the JH2 pseudokinase domain of Janus kinase 2 in bone marrow trephine biopsies derived from chronic myeloproliferative disorders. J Mol Diagn 8 (2006) 170-177
20. Bock O., Neuse J., Hussein K., Brakensiek K., Buesche G., Buhr T., et al. Aberrant collagenase expression in chronic idiopathic myelofibrosis is related to the stage of disease but not to the JAK2 mutation status. Am J Pathol 169 (2006) 471-481
21. Bousquet M., Quelen C., De Mas V., Duchayne E., Roquefeuil B., Delsol G., et al. The t(8;9)(p22;p24) translocation in atypical chronic myeloid leukaemia yields a new PCM1-JAK2 fusion gene. Oncogene 24 (2005) 7248-7252
22. Bousquet M., Le Guellec S., Quelen C., Rigal-Huguet F., Delsol G., and Brousset P. Frequent detection of the JAK2 V617F mutation in bone marrow core biopsy specimens from chronic myeloproliferative disorders using the TaqMan polymerase chain reaction single nucleotide polymorphism genotyping assay: a retrospective study with pathologic correlations. Hum Pathol 37 (2006) 1458-1464
23. Braunschweig R., Baur A.S., Delacretaz F., Bricod C., and Benhattar J. Contribution of IgH-PCR to the evaluation of B-cell lymphoma involvement in paraffin-embedded bone marrow biopsy specimens. Am J Clin Pathol 119 (2003) 634-642
24. Brinckmann R., Kaufmann O., Reinartz B., and Dietel M. Specificity of PCR-based clonality analysis of immunoglobulin heavy chain gene rearrangements for the detection of bone marrow involvement by low-grade B-cell lymphomas. J Pathol 190 (2000) 55-60
25. Bruggemann M., Pott C., Ritgen M., and Kneba M. Significance of minimal residual disease in lymphoid malignancies. Acta Haematol 112 (2004) 111-119
26. Bueso-Ramos C., Xu Y., McDonnell T.J., Brisbay S., Pierce S., Kantarjian H., et al. Protein expression of a triad of frequently methylated genes, p73, p57Kip2, and p15, has prognostic value in adult acute lymphocytic leukemia independently of its methylation status. J Clin Oncol 23 (2005) 3932-3939
27. Camp R.L., Chung G.G., and Rimm D.L. Automated subcellular localization and quantification of protein expression in tissue microarrays. Nat Med 8 (2002) 1323-1327
28. Campbell J.K., Matthews J.P., Seymour J.F., Wolf M.M., and Juneja S.K. Optimum trephine length in the assessment of bone marrow involvement in patients with diffuse large cell lymphoma. Ann Oncol 14 (2003) 273-276
29. Campo E., Miquel R., Krenacs L., Sorbara L., Raffeld M., and Jaffe E.S. Primary nodal marginal zone lymphomas of splenic and MALT type. Am J Surg Pathol 23 1 (1999) 59-68
30. Campo E., Raffeld M., and Jaffe E.S. Mantle cell lymphoma. Semin Hematol 36 (1999) 115-127
31. Cascavilla N., Musto P., D'Arena G., Melillo L., Carella A.M., Petrilli M.P., et al. CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype. Haematologica 83 (1998) 392-397
32. Caulet S., Delmer A., Audouin J., Le Tourneau A., Bernadou A., Zittoun R., et al. Histopathological study of bone marrow biopsies in 30 cases of T-cell lymphoma with clinical, biological and survival correlations. Hematol Oncol 8 (1990) 155-168
33. Ceesay M.M., Lea N.C., Ingram W., Westwood N.B., Gaken J., Mohamedali A., et al. The JAK2 V617F mutation is rare in RARS but common in RARS-T. Leukemia 20 (2006) 2060-2061
34. Cheson B.D., Bennett J.M., Kantarjian H., Pinto A., Schiffer C.A., Nimer S.D., et al. Report of an international working group to standardize response criteria for myelodysplastic syndromes. Blood 96 (2000) 3671-3674
35. Cheson B.D., Bennett J.M., Kopecky K.J., Buchner T., Willman C.L., Estey E.H., et al. Revised recommendations of the International Working Group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia. J Clin Oncol 21 (2003) 4642-4649
36. Chittal S.M., Brousset P., Voigt J.J., and Delsol G. Large B-cell lymphoma rich in T-cells and simulating Hodgkin's disease. Histopathology 19 (1991) 211-220
37. Chuang S.S., and Li C.Y. Useful panel of antibodies for the classification of acute leukemia by immunohistochemical methods in bone marrow trephine biopsy specimens. Am J Clin Pathol 107 (1997) 410-418
38. Cilloni D., Guerrasio A., Giugliano E., Scaravaglio P., Volpe G., Rege-Cambrin G., et al. From genes to therapy: the case of Philadelphia chromosome-positive leukemias. Ann N Y Acad Sci 963 (2002) 306-312
39. Coad J.E., Olson D.J., Christensen D.R., Lander T.A., Chibbar R., McGlennen R.C., et al. Correlation of PCR-detected clonal gene rearrangements with bone marrow morphology in patients with B-lineage lymphomas. Am J Surg Pathol 21 (1997) 1047-1056
40. Cohen P.L., Kurtin P.J., Donovan K.A., and Hanson C.A. Bone marrow and peripheral blood involvement in mantle cell lymphoma. Br J Haematol 101 (1998) 302-310
41. Cook J.R., Hartke M., Pettay J., and Tubbs R.R. Fluorescence in situ hybridization analysis of immunoglobulin heavy chain translocations in plasma cell myeloma using intact paraffin sections and simultaneous CD138 immunofluorescence. J Mol Diagn 8 (2006) 459-465
42. Cooke C.B., Krenacs L., Stetler-Stevenson M., Greiner T.C., Raffeld M., Kingma D.W., et al. Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin. Blood 88 (1996) 4265-4274
43. Cotelingam J.D. Bone marrow biopsy: interpretive guidelines for the surgical pathologist. Adv Anat Pathol 10 (2003) 8-26
44. Darby A.J., and Johnson P.W. Molecular remission and non-Hodgkin's lymphoma. Best Pract Res Clin Haematol 15 (2002) 549-562
45. Dave S.S., Wright G., Tan B., Rosenwald A., Gascoyne R.D., Chan W.C., et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med 351 (2004) 2159-2169
46. Deane M., McCarthy K.P., Wiedemann L.M., and Norton J.D. An improved method for detection of B-lymphoid clonality by polymerase chain reaction. Leukemia 5 (1991) 726-730
47. de Greef G., van Putten W., Boogaerts M., Huijgens P., Verdonck L., Vellenga E., et al. Criteria for defining a complete remission in acute myeloid leukaemia revisited. An analysis of patients treated in HOVON-SAKK co-operative group studies. Br J Haematol 128 (2005) 184-191
48. Deininger M.W., Goldman J.M., and Melo J.V. The molecular biology of chronic myeloid leukemia. Blood 96 (2000) 3343-3356
49. de Kok J.B., Roelofs R.W., Giesendorf B.A., Pennings J.L., Waas E.T., Feuth T., et al. Normalization of gene expression measurements in tumor tissues: comparison of 13 endogenous control genes. Lab Invest 85 (2005) 154-159
50. Derksen P.W., Langerak A.W., Kerkhof E., Wolvers-Tettero I.L., Boor P.P., Mulder A.H., et al. Comparison of different polymerase chain reaction-based approaches for clonality assessment of immunoglobulin heavy-chain gene rearrangements in B-cell neoplasia. Mod Pathol 12 (1999) 794-805
51. Diebold J., Molina T., Camilleri-Broet S., Le Tourneau A., and Audouin J. Bone marrow manifestations of infections and systemic diseases observed in bone marrow trephine biopsy review. Histopathology 37 (2000) 199-211
52. DiGiuseppe J.A., Hartmann D.P., Freter C., Cossman J., and Mann R.B. Molecular detection of bone marrow involvement in intravascular lymphomatosis. Mod Pathol 10 (1997) 33-37
53. Dogan A., and Morice W.G. Bone marrow histopathology in peripheral T-cell lymphomas. Br J Haematology 127 (2004) 140-154
54. Dolken G. Detection of minimal residual disease. Adv Cancer Res 82 (2001) 133-185
55. Dorfman D.M., and Shahsafaei A. Usefulness of a new CD5 antibody for the diagnosis of T-cell and B-cell lymphoproliferative disorders in paraffin sections. Mod Pathol 10 (1997) 859-863
56. Douglas V.K., Gordon L.I., Goolsby C.L., White C.A., and Peterson L.C. Lymphoid aggregates in bone marrow mimic residual lymphoma after rituximab therapy for non-Hodgkin lymphoma. Am J Clin Pathol 112 (1999) 844-853
57. Druker B.J., Sawyers C.L., Kantarjian H., Resta D.J., Reese S.F., Ford J.M., et al. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N Engl J Med 344 (2001) 1038-1042
58. Elenitoba-Johnson K.S., Bohling S.D., Mitchell R.S., Brown M.S., and Robetorye R.S. PCR analysis of the immunoglobulin heavy chain gene in polyclonal processes can yield pseudoclonal bands as an artifact of low B cell number. J Mol Diagn 2 (2000) 92-96
59. Ely S.A., and Knowles D.M. Expression of CD56/neural cell adhesion molecule correlates with the presence of lytic bone lesions in multiple myeloma and distinguishes myeloma from monoclonal gammopathy of undetermined significance and lymphomas with plasmocytoid differentiation. Am J Pathol 160 (2002) 1293-1299
60. Falini B., Tiacci E., Liso A., Basso K., Sabattini E., Pacini R., et al. Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1). Lancet 363 (2004) 1869-1870
61. Falini B., Mecucci C., Tiacci E., Alcalay M., Rosati R., Pasqualucci L., et al., the GALWP. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N Engl J Med 352 (2005) 254-266
62. Fend F., Weyrer K., Drach J., Schwaiger A., Umlauft F., and Grunewald K. Immunoglobulin gene rearrangement in plasma cell dyscrasias: detection of small clonal cell populations in peripheral blood and bone marrow. Leukemia Lymphoma 10 (1993) 223-229
63. Fend F., Gschwendtner A., Gredler E., Thaler J., and Dietze O. Detection of monoclonal B-cell populations in decalcified, plastic-embedded bone marrow biopsies with the polymerase chain reaction. Am J Clin Pathol 102 (1994) 850-855
64. Fend F., Quintanilla-Martinez L., Kumar S., Beaty M.W., Blum L., Sorbara L., et al. Composite low grade B-cell lymphomas with two immunophenotypically distinct cell populations are true biclonal lymphomas. A molecular analysis using laser capture microdissection. Am J Pathol 154 (1999) 1857-1866
65. Fend F., Kremer M., Specht K., and Quintanilla-Martinez L. Laser microdissection in hematopathology. Pathol Res Pract 199 (2003) 425-430
66. Fend F., Bock O., Kremer M., Specht K., and Quintanilla-Martinez L. Ancillary techniques in bone marrow pathology: molecular diagnostics on bone marrow trephine biopsies. Virchows Arch 447 (2005) 909-919
67. Ferry J.A., Yang W.I., Zukerberg L.R., Wotherspoon A.C., Arnold A., and Harris N.L. CD5+ extranodal marginal zone B-cell (MALT) lymphoma. A low grade neoplasm with a propensity for bone marrow involvement and relapse. Am J Clin Pathol 105 (1996) 31-37
68. Feugier P., De March A.K., Lesesve J.F., Monhoven N., Dorvaux V., Braun F., et al. Intravascular bone marrow accumulation in persistent polyclonal lymphocytosis: a misleading feature for B-cell neoplasm. Mod Pathol 17 (2004) 1087-1096
69. Foucar K. Bone marrow pathology (2001), ASCP Press, Chicago
70. Fraga M., Brousset P., Schlaifer D., Payen C., Robert A., Rubie H., et al. Bone marrow involvement in anaplastic large cell lymphoma. Immunohistochemical detection of minimal disease and its prognostic significance. Am J Clin Pathol 103 (1995) 82-89
71. Franco V., Florena A.M., and Iannitto E. Splenic marginal zone lymphoma. Blood 101 (2003) 2464-2472
72. Gaulard P., Kanavaros P., Farcet J.P., Rocha F.D., Haioun C., Divine M., et al. Bone marrow histologic and immunohistochemical findings in peripheral T-cell lymphoma: a study of 38 cases. Hum Pathol 22 (1991) 331-338
73. Gebhard S., Benhattar J., Bricod C., Meuge-Moraw C., and Delacretaz F. Polymerase chain reaction in the diagnosis of T-cell lymphoma in paraffin-embedded bone marrow biopsies: a comparative study. Histopathology 38 (2001) 37-44
74. Ghani A.M., and Krause J.R. Bone marrow biopsy findings in angioimmunoblastic lymphadenopathy. Br J Haematol 61 (1985) 203-213
75. Godfrey T.E., Kim S.H., Chavira M., Ruff D.W., Warren R.S., Gray J.W., et al. Quantitative mRNA expression analysis from formalin-fixed, paraffin-embedded tissues using 5′ nuclease quantitative reverse transcription-polymerase chain reaction. J Mol Diagn 2 (2000) 84-91
76. Gong J.Z., Zheng S., Chiarle R., De Wolf-Peeters C., Palestro G., Frizzera G., et al. Detection of immunoglobulin kappa light chain rearrangements by polymerase chain reaction. An improved method for detecting clonal B-cell lymphoproliferative disorders. Am J Pathol 155 (1999) 355-363
77. Greiner T.C., Moynihan M.J., Chan W.C., Lytle D.M., Pedersen A., Anderson J.R., et al. p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis. Blood 87 (1996) 4302-4310
78. Grogan T.M. Plasma cell myeloma marrow diagnosis including morphologic and phenotypic features. Semin Diagn Pathol 20 (2003) 211-225
79. Grunewald K., Lyons J., Hansen-Hagge T.E., Janssen J.W., Feichtinger H., and Bartram C.R. Molecular genetic analysis of DNA obtained from fixed, air dried or paraffin embedded sources. Ann Hematol 62 (1991) 108-114
80. Hakimian D., Tallman M.S., Kiley C., and Peterson L. Detection of minimal residual disease by immunostaining of bone marrow biopsies after 2-chlorodeoxyadenosine for hairy cell leukemia. Blood 82 (1993) 1798-1802
81. Hanamura A., Kinoshita T., Kurokawa T., Nagai H., Murate T., Nagasaka T., et al. Molecular evaluation of bone marrow involvement in peripheral T-cell lymphoma with a PCR-mediated RNase protection assay. Int J Hematol 70 (1999) 283-289
82. Hanson C.A., Kurtin P.J., Katzmann J.A., Hoyer J.D., Li C.Y., Hodnefield J.M., et al. Immunophenotypic analysis of peripheral blood and bone marrow in the staging of B-cell malignant lymphoma. Blood 94 (1999) 3889-3896
83. Harris N.L., and Bhan A.K. B-cell neoplasms of the lymphocytic, lymphoplasmacytoid, and plasma cell types: immunohistologic analysis and clinical correlation. Hum Pathol 16 (1985) 829-837
84. Henrique R., Achten R., Maes B., Verhoef G., and De Wolf-Peeters C. Guidelines for subtyping small B-cell lymphomas in bone marrow biopsies. Virchows Arch 435 (1999) 549-558
85. Hernandez L., Fest T., Cazorla M., Teruya-Feldstein J., Bosch F., Peinado M.A., et al. p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas. Blood 87 8 (1996) 3351-3359
86. Hideshima T., Bergsagel P.L., Kuehl W.M., and Anderson K.C. Advances in biology of multiple myeloma: clinical applications. Blood 104 (2004) 607-618
87. Hoeve M.A., Krol A.D., Philippo K., Derksen P.W., Veenendaal R.A., Schuuring E., et al. Limitations of clonality analysis of B cell proliferations using CDR3 polymerase chain reaction. Mol Pathol 53 (2000) 194-200
88. Horn T., Kremer M., Dechow T., Pfeifer W.M., Geist B., Perker M., et al. Detection of the activating JAK2 V617F mutation in paraffin-embedded trephine bone marrow biopsies of patients with chronic myeloproliferative diseases. J Mol Diagn 8 (2006) 299-304
89. Horny H.P., Wehrmann M., Steinke B., and Kaiserling E. Assessment of the value of immunohistochemistry in the subtyping of acute leukemia on routinely processed bone marrow biopsy specimens with particular reference to macrophage-associated antibodies. Hum Pathol 25 (1994) 810-814
90. Horny H.P., Wehrmann M., Schlicker H.U., Eichstaedt A., Clemens M.R., and Kaiserling E. QBEND10 for the diagnosis of myelodysplastic syndromes in routinely processed bone marrow biopsy specimens. J Clin Pathol 48 (1995) 291-294
91. Howell S.J., Grey M., Chang J., Morgenstern G.R., Cowan R.A., Deakin D.P., et al. The value of bone marrow examination in the staging of Hodgkin's lymphoma: a review of 955 cases seen in a regional cancer centre. Br J Haematol 119 (2002) 408-411
92. Hoyer J.D., Li C.Y., Yam L.T., Hanson C.A., and Kurtin P.J. Immunohistochemical demonstration of acid phosphatase isoenzyme 5 (tartrate-resistant) in paraffin sections of hairy cell leukemia and other hematologic disorders. Am J Clin Pathol 108 (1997) 308-315
93. Hurwitz N. Bone marrow trephine biopsy changes following chemotherapy and/or bone marrow transplantation. Curr Diagn Pathol (1997) 196-202
94. Hussein K., Brakensiek K., Ballmaier M., Bormann M., Gohring G., Buhr T., et al. B-CLL developing in a patient with PV is not affected by V617F mutation of the Janus kinase 2. Eur J Haematol 77 (2006) 539-541
95. Ioachim H.L., Dorsett B., Cronin W., Maya M., and Wahl S. Acquired immunodeficiency syndrome-associated lymphomas: clinical, pathologic, immunologic, and viral characteristics of 111 cases. Hum Pathol 22 (1991) 659-673
96. In: Jaffe E.S., Harris N.L., Stein H., and Vardimann J.W. (Eds). Pathology and genetics of tumours of the hematopoietic and lymphoid tissue (2001), IARC Press, Lyon
97. James C., Ugo V., Le Couedic J.P., Staerk J., Delhommeau F., Lacout C., et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 434 (2005) 1144-1148
98. Johrens K., Stein H., and Anagnostopoulos I. T-bet transcription factor detection facilitates the diagnosis of minimal hairy cell leukemia infiltrates in bone marrow trephines. Am J Surg Pathol 31 (2007) 1181-1185
99. Kent S.A., Variakojis D., and Peterson L.C. Comparative study of marginal zone lymphoma involving bone marrow. Am J Clin Pathol 117 (2002) 698-708
100. Khoury J.D., Jones D., Yared M.A., Manning Jr. J.T., Abruzzo L.V., Hagemeister F.B., et al. Bone marrow involvement in patients with nodular lymphocyte predominant Hodgkin lymphoma. Am J Surg Pathol 28 (2004) 489-495
101. Koch I., Slotta-Huspenina J., Hollweck R., Hofler H., Quintanilla-Martinez L., and Fend F. Real-time quantitative RT-PCR shows variable, assay-dependent sensitivity to formalin fixation: implications for direct comparison of transcript levels in paraffin-embedded tissues. Diagn Mol Pathol 15 (2006) 149-156
102. Kononen J., Bubendorf L., Kallioniemi A., Barlund M., Schraml P., Leighton S., et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4 (1998) 844-847
103. Koopmans M., Monroe S.S., Coffield L.M., and Zaki S.R. Optimization of extraction and PCR amplification of RNA extracts from paraffin-embedded tissue in different fixatives. J Virol Methods 43 (1993) 189-204
104. Korac P., Jones M., Dominis M., Kusec R., Mason D.Y., Banham A.H., et al. Application of the FICTION technique for the simultaneous detection of immunophenotype and chromosomal abnormalities in routinely fixed, paraffin wax embedded bone marrow trephines. J Clin Pathol 58 (2005) 1336-1338
105. Krafft A.E., Duncan B.W., Bijwaard K.E., Taubenberger J.K., and Lichy J.H. Optimization of the isolation and amplification of RNA from formalin-fixed, paraffin-embedded tissue: The Armed Forces Institute of Pathology experience and literature review. Mol Diagn 2 (1997) 217-230
106. Kralovics R., Passamonti F., Buser A.S., Teo S.S., Tiedt R., Passweg J.R., et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 352 (2005) 1779-1790
107. Kremer M., Cabras A.D., Fend F., Schulz S., Schwarz K., Hoefler H., et al. PCR analysis of IgH-gene rearrangements in small lymphoid infiltrates microdissected from sections of paraffin-embedded bone marrow biopsy specimens. Hum Pathol 31 (2000) 847-853
108. Kremer M., Dirnhofer S., Nickl A., Hoefler H., Quintanilla-Martinez L., and Fend F. p27kip1 immunostaining for the differential diagnosis of small B-cell neoplasms in trephine bone marrow biopsies. Mod Pathol 14 (2001) 1022-1029
109. Kremer M., Sandherr M., Geist B., Cabras A.D., Hofler H., and Fend F. Epstein-Barr virus-negative Hodgkin's lymphoma after mycosis fungoides: molecular evidence for distinct clonal origin. Mod Pathol 14 (2001) 91-97
110. Kremer M., Spitzer M., Mandl-Weber S., Stecker K., Schmidt B., Hofler H., et al. Discordant bone marrow involvement in diffuse large B-cell lymphoma: comparative molecular analysis reveals a heterogeneous group of disorders. Lab Invest 83 (2003) 107-114
111. Kremer M., Quintanilla-Martinez L., Nahrig J., von Schilling C., and Fend F. Immunohistochemistry in bone marrow pathology: a useful adjunct for morphologic diagnosis. Virchows Arch 447 (2005) 920-937
112. Kremer M., Horn T., Dechow T., Tzankov A., Quintanilla-Martinez L., and Fend F. THe JAK2 V617F mutation occurs frequently in myelodysplastic/myeloproliferative diseases, but is absent from true myelodysplastic syndromes with fibrosis. Leukemia 20 (2006) 1315-1316
113. Kremer M, Horn T, Koch I, Pfeifer WM, Tzankov A, Gattenlöhner S, et al. Quantitation of the JAK2V617F mutation in microdissected bone marrow trephines: equal mutational load in myeloid lineages and rare involvement of lymphoid cells. Am J Surg Pathol, in press.
114. Krenacs T., Bagdi E., Stelkovics E., Bereczki L., and Krenacs L. How we process trephine biopsy specimens: epoxy resin embedded bone marrow biopsies. J Clin Pathol 58 (2005) 897-903
115. Kreuzer K.A., Lass U., Nagel S., Ellerbrok H., Pauli G., Pawlaczyk-Peter B., et al. Applicability of an absolute quantitative procedure to monitor intra-individual bcr/abl transcript kinetics in clinical samples from chronic myelogenous leukemia patients. Int J Cancer 86 (2000) 741-746
116. Krober S.M., Greschniok A., Kaiserling E., and Horny H.P. Acute lymphoblastic leukaemia: correlation between morphological/immunohistochemical and molecular biological findings in bone marrow biopsy specimens. Mol Pathol 53 (2000) 83-87
117. Kumar S., Green G.A., Teruya-Feldstein J., Raffeld M., and Jaffe E.S. Use of CD23 (BU38) on paraffin sections in the diagnosis of small lymphocytic lymphoma and mantle cell lymphoma. Mod Pathol 9 (1996) 925-929
118. Lai R., Weiss L.M., Chang K.L., and Arber D.A. Frequency of CD43 expression in non-Hodgkin lymphoma. A survey of 742 cases and further characterization of rare CD43+ follicular lymphomas. Am J Clin Pathol 111 (1999) 488-494
119. Le Maitre C.L., Byers R.J., Liu Yin J.A., Hoyland J.A., and Freemont A.J. Dual colour FISH in paraffin wax embedded bone trephines for identification of numerical and structural chromosomal abnormalities in acute myeloid leukaemia and myelodysplasia. J Clin Pathol 54 (2001) 730-733
120. Lehmann U., and Kreipe H. Real-time PCR analysis of DNA and RNA extracted from formalin-fixed and paraffin-embedded biopsies. Methods 25 (2001) 409-418
121. Lehmann U., Bock O., Langer F., and Kreipe H. Demonstration of light chain restricted clonal B-lymphoid infiltrates in archival bone marrow trephines by quantitative real-time polymerase chain reaction. Am J Pathol 159 (2001) 2023-2029
122. Levine R.L., Wadleigh M., Cools J., Ebert B.L., Wernig G., Huntly B.J., et al. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell 7 (2005) 387-397
123. Lewis F., Maughan N.J., Smith V., Hillan K., and Quirke P. Unlocking the archive - gene expression in paraffin-embedded tissue. J Pathol 195 (2001) 66-71
124. Lim E.J., and Peh S.C. Bone marrow and peripheral blood changes in non-Hodgkin's lymphoma. Singapore Med J 41 (2000) 279-285
125. Limpens J., de Jong D., van Krieken J.H., Price C.G., Young B.D., van Ommen G.J., et al. Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia. Oncogene 6 (1991) 2271-2276
126. Limpens J., Stad R., Vos C., de Vlaam C., de Jong D., van Ommen G.J., et al. Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals. Blood 85 (1995) 2528-2536
127. Louie D.C., Offit K., Jaslow R., Parsa N.Z., Murty V.V., Schluger A., et al. p53 overexpression as a marker of poor prognosis in mantle cell lymphomas with t(11;14)(q13;q32). Blood 86 8 (1995) 2892-2899
128. Lugli A., Ebnoether M., Cogliatti S.B., Gratwohl A., Passweg J., Hess U., et al. Proposal of a morphologic bone marrow response score for imatinib mesylate treatment in chronic myelogenous leukemia. Hum Pathol 36 (2005) 91-100
129. Manaloor E.J., Neiman R.S., Heilman D.K., Albitar M., Casey T., Vattuone T., et al. Immunohistochemistry can be used to subtype acute myeloid leukemia in routinely processed bone marrow biopsy specimens. Comparison with flow cytometry. Am J Clin Pathol 113 (2000) 814-822
130. Mao Z.R., Quintanilla-Martinez L., Raffeld M., Richter M., Krugmann J., Burek C., et al. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent two different pathways of disease evolution. Am J Surg Pathol 31 (2007) 1605-1614
131. Martin-Subero J.I., Chudoba I., Harder L., Gesk S., Grote W., Novo F.J., et al. Multicolor-FICTION: expanding the possibilities of combined morphologic, immunophenotypic, and genetic single cell analyses. Am J Pathol 161 (2002) 413-420
132. Masir N., Marafioti T., Jones M., Natkunam Y., Rudiger T., Hansmann M.L., et al. Loss of CD19 expression in B-cell neoplasms. Histopathology 48 (2006) 239-246
133. Masuda N., Ohnishi T., Kawamoto S., Monden M., and Okubo K. Analysis of chemical modification of RNA from formalin-fixed samples and optimization of molecular biology applications for such samples. Nucleic Acids Res 27 (1999) 4436-4443
134. McCarthy K.P., Sloane J.P., and Wiedemann L.M. Rapid method for distinguishing clonal from polyclonal B cell populations in surgical biopsy specimens. J Clin Pathol 43 (1990) 429-432
135. McCarthy K.P., Sloane J.P., Kabarowski J.H., Matutes E., and Wiedemann L.M. A simplified method of detection of clonal rearrangements of the T-cell receptor-gamma chain gene. Diagn Mol Pathol 1 (1992) 173-179
136. Miranda R.N., Mark H.F., and Medeiros L.J. Fluorescent in situ hybridization in routinely processed bone marrow aspirate clot and core biopsy sections. Am J Pathol 145 (1994) 1309-1314
137. Morice W.G., Kurtin P.J., Tefferi A., and Hanson C.A. Distinct bone marrow findings in T-cell granular lymphocytic leukemia revealed by paraffin section immunoperoxidase stains for CD8, TIA-1, and granzyme B. Blood 99 (2002) 268-274
138. Nagasaka T., Lai R., Chen Y.Y., Chen W., Arber D.A., Chang K.L., et al. The use of archival bone marrow specimens in detecting B-cell non-Hodgkin's lymphomas using polymerase chain reaction methods. Leukemia Lymphoma 36 (2000) 347-352
139. Obermann E.C., Marienhagen J., Stoehr R., Wuensch P.H., and Hofstaedter F. Tissue microarray construction from bone marrow biopsies. Biotechniques 39 (2005) 822-826
140. Ogata K., Nakamura K., Yokose N., Tamura H., Tachibana M., Taniguchi O., et al. Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndrome. Blood 100 (2002) 3887-3896
141. Orazi A., Neiman R.S., Cualing H., Heerema N.A., and John K. CD34 immunostaining of bone marrow biopsy specimens is a reliable way to classify the phases of chronic myeloid leukemia. Am J Clin Pathol 101 (1994) 426-428
142. Orazi A., Chiu R., O'Malley D.P., Czader M., Allen S.L., An C., et al. Chronic myelomonocytic leukemia: the role of bone marrow biopsy immunohistology. Mod Pathol 19 (2006) 1536
143. Orazi A., O'Malley D., and Arber D.A. Illustrated pathology of the bone marrow (2006), Cambridge University Press, Cambridge
144. Orchard J.A., Ibbotson R.E., Davis Z., Wiestner A., Rosenwald A., Thomas P.W., et al. ZAP-70 expression and prognosis in chronic lymphocytic leukaemia. The Lancet 363 (2004) 105
145. Ott G., Ott M.M., Kalla J., Helbing A., Schryen B., Katzenberger T., et al. Genetic lesions in mantle cell lymphoma. Recent Results Cancer Res 143 (1997) 307-319
146. Ott G., Kalla J., Hanke A., Muller J.G., Rosenwald A., Katzenberger T., et al. The cytomorphological spectrum of mantle cell lymphoma is reflected by distinct biological features. Leukemia Lymphoma 32 (1998) 55-63
147. Packeisen J., Korsching E., Herbst H., Boecker W., and Buerger H. Demystified tissue microarray technology. Mol Pathol 56 (2003) 198-204
148. Pajor L., Lacza A., Kereskai L., Jakso P., Egyed M., Ivanyi J.L., et al. Increased incidence of monoclonal B-cell infiltrate in chronic myeloproliferative disorders. Mod Pathol 17 (2004) 1521-1530
149. Palacio C., Acebedo G., Navarrete M., Ruiz-Marcellan C., Sanchez C., Blanco A., et al. Flow cytometry in the bone marrow evaluation of follicular and diffuse large B-cell lymphomas. Haematologica 86 (2001) 934-940
150. Pardanani A.D., Levine R.L., Lasho T., Pikman Y., Mesa R.A., Wadleigh M., et al. MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients. Blood 108 (2006) 3472-3476
151. Perz J., Topaly J., Fruehauf S., Hensel M., and Ho A.D. Level of CD 20-expression and efficacy of rituximab treatment in patients with resistant or relapsing B-cell prolymphocytic leukemia and B-cell chronic lymphocytic leukemia. Leukemia Lymphoma 43 (2002) 149-151
152. Peterson L.A., and Brunning R.D. Bone marrow specimen processing. In: Knowles D.M. (Ed). Neoplastic hematopathology (2001), Lippincott Williams & Wilkins, Philadelphia 1391-1406
153. Pikman Y., Lee B.H., Mercher T., McDowell E., Ebert B.L., Gozo M., et al. MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia. PLoS Med 3 (2006) e270
154. Pileri S.A., Ascani S., Milani M., Visani G., Piccioli M., Orcioni G.F., et al. Acute leukemia immunophenotyping in bone-marrow routine sections. Br J Haematol 105 (1999) 394-401
155. Pittaluga S., Tierens A., Dodoo Y.L., Delabie J., and De Wolf-Peeters C. How reliable is histologic examination of bone marrow trephine biopsy specimens for the staging of non-Hodgkin lymphoma? A study of hairy cell leukemia and mantle cell lymphoma involvement of the bone marrow trephine specimen by histologic, immunohistochemical, and polymerase chain reaction techniques. Am J Clin Pathol 111 (1999) 179-184
156. Provan A.B., Hodges E., Smith A.G., and Smith J.L. Use of paraffin wax embedded bone marrow trephine biopsy specimens as a source of archival DNA. J Clin Pathol 45 (1992) 763-765
157. Quintanilla-Martínez L., Thieblemont C., Fend F., Kumar S., Pinyol M., Campo E., et al. Mantle cell lymphomas lack expression of p27/kip1, a cyclin-dependent kinase inhibitor. Am J Pathol 153 (1998) 175-182
158. Quintanilla-Martinez L., Fend F., Rodriguez Moguel L., Spilove L., Beaty M.W., et al. Peripheral T-cell lymphoma with Reed-Sternberg-like cells of B-cell phenotype and genotype associated with Epstein-Barr virus infection. Am J Surg Pathol 23 (1999) 1233-1240
159. Raffeld M., and Jaffe E.S. bcl-1, t(11;14) and mantle cell-derived lymphomas. Blood 78 (1991) 259-263
160. Reineke T., Jenni B., Abdou M.T., Frigerio S., Zubler P., Moch H., et al. Ultrasonic decalcification offers new perspectives for rapid FISH, DNA, and RT-PCR analysis in bone marrow trephines. Am J Surg Pathol 30 (2006) 892-896
161. Rimsza L., Viswanatha D., Winter S., Leith C., Frost J., and Foucar K. The presence of CD34+ cell clusters predicts impending relapse in children with acute lymphoblastic leukemia receiving maintenance chemotherapy. Am J Clin Pathol 110 (1998) 313-320
162. Rimsza L.M., Larson R.S., Winter S.S., Foucar K., Chong Y.Y., Garner K.W., et al. Benign hematogone-rich lymphoid proliferations can be distinguished from B-lineage acute lymphoblastic leukemia by integration of morphology, immunophenotype, adhesion molecule expression, and architectural features. Am J Clin Pathol 114 (2000) 66-75
163. Rizzatti E.G., Garcia A.B., Portieres F.L., Silva D.E., Martins S.L., and Falcao R.P. Expression of CD117 and CD11b in bone marrow can differentiate acute promyelocytic leukemia from recovering benign myeloid proliferation. Am J Clin Pathol 118 (2002) 31-37
164. Rosenwald A., Alizadeh A.A., Widhopf G., Simon R., Davis R.E., Yu X., et al. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med 194 (2001) 1639-1648
165. Rosenwald A., Wright G., Wiestner A., Chan W.C., Connors J.M., Campo E., et al. The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell 3 (2003) 185-197
166. Schaefer H.E. Histological processing of iliac crest biopsies based on decalcification and paraffin embedding with reference to osteolytic and hematologic diagnosis. Pathologe 16 (1995) 11-27
167. Schmid C., and Isaacson P.G. Bone marrow trephine biopsy in lymphoproliferative disease. J Clin Pathol 45 (1992) 745-750
168. Schmidt B., Kremer M., Gotze K., John K., Peschel C., Hofler H., et al. Bone marrow involvement in follicular lymphoma: comparison of histology and flow cytometry as staging procedures. Leukemia Lymphoma 47 (2006) 1857-1862
169. Schulz S., Cabras A.D., Kremer M., Weirich G., Miethke T., Bosmuller H.C., et al. Species identification of mycobacteria in paraffin-embedded tissues: frequent detection of nontuberculous mycobacteria. Mod Pathol 18 (2005) 274-282
170. Scott L.M., Tong W., Levine R.L., Scott M.A., Beer P.A., Stratton M.R., et al. JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis. N Engl J Med 356 (2007) 459-468
171. Seliem R.M., Freeman J.K., Steingart R.H., and Hasserjian R.P. Immunophenotypic changes and clinical outcome in B-cell lymphomas treated with rituximab. Appl Immunohistochem Mol Morphol 14 (2006) 18-23
172. Sibaud V., Beylot-Barry M., Thiebaut R., Parrens M., Vergier B., Delaunay M., et al. Bone marrow histopathologic and molecular staging in epidermotropic T-cell lymphomas. Am J Clin Pathol 119 (2003) 414-423
173. Simon R., and Sauter G. Tissue microarrays for miniaturized high-throughput molecular profiling of tumors. Exp Hematol 30 (2002) 1365-1372
174. Slotta-Huspenina J, Koch I, Richter M, Bink K, Kremer M, Specht K et al. Cyclin D1 positive multiple myeloma: predominance of the short, 3′-UTR deficient transcript is associated with high cyclin D1 mRNAlevelsin cases with the t(11;14) translocation, but does not correlate with proliferation rate or genomic deletions. Leukemia Res 2007; in press.
175. Soslow R.A., Bhargava V., and Warnke R.A. MIC2, TdT, bcl-2, and CD34 expression in paraffin-embedded high-grade lymphoma/acute lymphoblastic leukemia distinguishes between distinct clinicopathologic entities. Hum Pathol 28 (1997) 1158-1165
176. Sotlar K., Escribano L., Landt O., Mohrle S., Herrero S., Torrelo A., et al. One-step detection of c-kit point mutations using peptide nucleic acid-mediated polymerase chain reaction clamping and hybridization probes. Am J Pathol 162 (2003) 737-746
177. Sotlar K., Horny H.P., Simonitsch I., Krokowski M., Aichberger K.J., Mayerhofer M., et al. CD25 indicates the neoplastic phenotype of mast cells: a novel immunohistochemical marker for the diagnosis of systemic mastocytosis (SM) in routinely processed bone marrow biopsy specimens. Am J Surg Pathol 28 (2004) 1319-1325
178. Specht K., Richter T., Müller U., Walch A., Werner M., and Höfler H. Quantitative gene expression analysis in microdissected archival formalin-fixed, paraffin-embedded tumor tissue. Am J Pathol 158 (2001) 419-429
179. Specht K., Kremer M., Muller U., Dirnhofer S., Rosemann M., Hofler H., et al. Identification of cyclin D1 mRNA overexpression in B-cell neoplasias by real-time reverse transcription-PCR of microdissected paraffin sections. Clin Cancer Res 8 (2002) 2902-2911
180. Specht K., Haralambieva E., Bink K., Kremer M., Mandl-Weber S., Koch I., et al. Different mechanisms of cyclin D1 overexpression in multiple myeloma revealed by fluorescence in situ hybridization and quantitative analysis of mRNA levels. Blood 104 (2004) 1120-1126
181. Srinivasan M., Sedmak D., and Jewell S. Effect of fixatives and tissue processing on the content and integrity of nucleic acids. Am J Pathol 161 (2002) 1961-1971
182. Stacchini A., Demurtas A., Godio L., Martini G., Antinoro V., and Palestro G. Flow cytometry in the bone marrow staging of mature B-cell neoplasms. Cytometry B (Clin Cytometry) 54 (2003) 10-18
183. Stein H., Foss H.D., Durkop H., Marafioti T., Delsol G., Pulford K., et al. CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood 96 (2000) 3681-3695
184. Subira M., Domingo A., Santamaria A., Bordes R., Romagosa V., and Soler J. Bone marrow involvement in lymphoblastic lymphoma and small non-cleaved cell lymphoma: the role of trephine biopsy. Haematologica 82 (1997) 594-595
185. Sundeen J.T., Longo D.L., and Jaffe E.S. CD5 expression in B-cell small lymphocytic malignancies. Correlations with clinical presentation and sites of disease. Am J Surg Pathol 16 (1992) 130-137
186. Swerdlow S.H., and Williams M.E. From centrocytic to mantle cell lymphoma: a clinicopathologic and molecular review of 3 decades. Hum Pathol 33 (2002) 7-20
187. Szpurka H., Tiu R., Murugesan G., Aboudola S., Hsi E.D., Theil K.S., et al. Refractory anemia with ringed sideroblasts associated with marked thrombocytosis (RARS-T), another myeloproliferative condition characterized by JAK2 V617F mutation. Blood 108 (2006) 2173-2181
188. Taylor M.L., Sehgal D., Raffeld M., Obiakor H., Akin C., Mage R.G., et al. Demonstration that mast cells, T cells, and B cells bearing the activating kit mutation D816V occur in clusters within the marrow of patients with mastocytosis. J Mol Diagn 6 (2004) 335-342
189. Tbakhi A., Totos G., Pettay J.D., Myles J., and Tubbs R.R. The effect of fixation on detection of B-cell clonality by polymerase chain reaction. Mod Pathol 12 (1999) 272-278
190. Temple G.K., Sales M., Kernohan N., Scott F., Meiklejohn D., and Pratt N. Application of combined immunofluorescence and fluorescence in situ hybridization on paraffin-embedded sections to characterize T-cell lymphoma with EBV-infected B-cell blasts. Genes Chromosomes Cancer 41 (2004) 405-409
191. Thaler J., Greil R., Dietze O., and Huber H. Immunohistology for quantification of normal bone marrow lymphocyte subsets. Br J Haematol 73 (1989) 576-577
192. Thieblemont C., Berger F., Dumontet C., Moullet I., Bouafia F., Felman P., et al. Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed. Blood 95 (2000) 802-806
193. Thiele J., Zirbes T.K., Kvasnicka H.M., and Fischer R. Focal lymphoid aggregates (nodules) in bone marrow biopsies: differentiation between benign hyperplasia and malignant lymphoma - a practical guideline. J Clin Pathol 52 (1999) 294-300
194. Tiacci E., Pileri S., Orleth A., Pacini R., Tabarrini A., Frenguelli F., et al. PAX5 expression in acute leukemias: higher B-lineage specificity than CD79a and selective association with t(8;21)-acute myelogenous leukemia. Cancer Res 64 (2004) 7399-7404
195. Torlakovic E., Torlakovic G., and Brunning R.D. Follicular pattern of bone marrow involvement by follicular lymphoma. Am J Clin Pathol 118 (2002) 780-786
196. Toth B., Wehrmann M., Kaiserling E., and Horny H.P. Immunophenotyping of acute lymphoblastic leukaemia in routinely processed bone marrow biopsy specimens. J Clin Pathol 52 (1999) 688-692
197. Troussard X., Valensi F., Duchayne E., Garand R., Felman P., Tulliez M., et al. Splenic lymphoma with villous lymphocytes: clinical presentation, biology and prognostic factors in a series of 100 patients. Groupe Francais d'Hematologie Cellulaire (GFHC). Br J Haematol 93 3 (1996) 731-736
198. Tworek J.A., Singleton T.P., Schnitzer B., Hsi E.D., and Ross C.W. Flow cytometric and immunohistochemical analysis of small lymphocytic lymphoma, mantle cell lymphoma, and plasmacytoid small lymphocytic lymphoma. Am J Clin Pathol 110 (1998) 582-589
199. Tzankov A., and Heiss S. Myeloproliferative disorders carrying the t(8;9) (PCM1-JAK2) translocation-reply. Hum Pathol 37 (2006) 500-502
200. Tzankov A., Went P., Zimpfer A., and Dirnhofer S. Tissue microarray technology: principles, pitfalls and perspectives - lessons learned from hematological malignancies. Exp Gerontol 40 (2005) 737-744
201. Valent P., Akin C., Escribano L., Fodinger M., Hartmann K., Brockow K., et al. Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Invest 37 (2007) 435-453
202. van Dongen J.J., Langerak A.W., Bruggemann M., Evans P.A., Hummel M., Lavender F.L., et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 17 (2003) 2257-2317
203. Vardiman J.W., Harris N.L., and Brunning R.D. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 100 (2002) 2292-2302
204. Vega F., Medeiros L.J., Bueso-Ramos C., Jones D., Lai R., Luthra R., et al. Hepatosplenic gamma/delta T-cell lymphoma in bone marrow. A sinusoidal neoplasm with blastic cytologic features. Am J Clin Pathol 116 3 (2001) 410-419
205. Viswanatha D., and Foucar K. Hodgkin and non-Hodgkin lymphoma involving bone marrow. Semin Diagn Pathol 20 (2003) 196-210
206. Weber-Matthiesen K., Winkemann M., Muller-Hermelink A., Schlegelberger B., and Grote W. Simultaneous fluorescence immunophenotyping and interphase cytogenetics: a contribution to the characterization of tumor cells. J Histochem Cytochem 40 (1992) 171-175
207. Weber-Matthiesen K., Pressl S., Schlegelberger B., and Grote W. Combined immunophenotyping and interphase cytogenetics on cryostat sections by the new FICTION method. Leukemia 7 (1993) 646-649
208. Weber-Matthiesen K., Deerberg J., Poetsch M., Grote W., and Schlegelberger B. Clarification of dubious karyotypes in Hodgkin's disease by simultaneous fluorescence immunophenotyping and interphase cytogenetics (FICTION). Cytogenet Cell Genet 70 (1995) 243-245
209. Weirich G., Funk A., Hoepner I., Heider U., Noll S., Putz B., et al. PCR-based assays for the detection of monoclonality in non-Hodgkin's lymphoma: application to formalin-fixed, paraffin-embedded tissue and decalcified bone marrow samples. J Mol Med 73 (1995) 235-241
210. Weirich G., Sandherr M., Fellbaum C., Richter T., Schmidt L., Kinjerski T., et al. Molecular evidence of bone marrow involvement in advanced case ot Tgammadelta lymphoma with secondary myelofibrosis. Hum Pathol 29 (1998) 761-765
211. Went P.T., Zimpfer A., Pehrs A.C., Sabattini E., Pileri S.A., Maurer R., et al. High specificity of combined TRAP and DBA.44 expression for hairy cell leukemia. Am J Surg Pathol 29 (2005) 474-478
212. West R.B., Warnke R.A., and Natkunam Y. The usefulness of immunohistochemistry in the diagnosis of follicular lymphoma in bone marrow biopsy specimens. Am J Clin Pathol 117 (2002) 636-643
213. Wickham C.L., Boyce M., Joyner M.V., Sarsfield P., Wilkins B.S., Jones D.B., et al. Amplification of PCR products in excess of 600 base pairs using DNA extracted from decalcified, paraffin wax embedded bone marrow trephine biopsies. Mol Pathol 53 (2000) 19-23
214. Wiestner A., Rosenwald A., Barry T.S., Wright G., Davis R.E., Henrickson S.E., et al. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood 101 (2003) 4944-4951
215. Yamaguchi M., Seto M., Okamoto M., Ichinohasama R., Nakamura N., Yoshino T., et al. De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients. Blood 99 (2002) 815-821
216. Zanotti R., Ambrosetti A., Lestani M., Ghia P., Pattaro C., Remo A., et al. ZAP-70 expression, as detected by immunohistochemistry on bone marrow biopsies from early-phase CLL patients, is a strong adverse prognostic factor. Leukemia 21 (2006) 102
217. Zhang P.J., Barcos M., Stewart C.C., Block A.W., Sait S., and Brooks J.J. Immunoreactivity of MIC2 (CD99) in acute myelogenous leukemia and related diseases. Mod Pathol 13 (2000) 452-458
218. Zhao X., Huang Q., Slovak M., and Weiss L. Comparison of ancillary studies in the detection of residual disease in plasma cell myeloma in bone marrow. Am J Clin Pathol 125 (2006) 895-904
219. Zhou X.G., Sandvej K., Gregersen N., and Hamilton-Dutoit S.J. Detection of clonal B cells in microdissected reactive lymphoproliferations: possible diagnostic pitfalls in PCR analysis of immunoglobulin heavy chain gene rearrangement. Mol Pathol 52 (1999) 104-110
220. Zimpfer A., Schonberg S., Lugli A., Agostinelli C., Pileri S.A., Went P., et al. Construction and validation of a bone marrow tissue microarray. J Clin Pathol 60 (2007) 57-61
221. Zoubek A., Ladenstein R., Windhager R., Amann G., Fischmeister G., Kager L., et al. Predictive potential of testing for bone marrow involvement in Ewing tumor patients by RT-PCR: a preliminary evaluation. Int J Cancer 79 (1998) 56-60